Cardiovascular risk factors before and during pregnancy: Does pregnancy unmask or initiate risk?

Emily W Harville1, Carrie E Crook2, Lydia A Bazzano1

  • 1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.

Insights

Pregnancy does not appear to cause new cardiovascular risks. Women with higher cardiovascular risk factors before pregnancy tend to maintain them during pregnancy, suggesting pre-existing susceptibility.

Area of Science:

  • Cardiovascular Health
  • Reproductive Health
  • Metabolic Health

Background:

  • Pregnancy can reveal or exacerbate underlying cardiovascular risks.
  • Understanding cardiovascular risk factors during pregnancy is crucial for maternal and fetal health.

Purpose of the Study:

  • To determine if pregnancy unmasks silent cardiovascular (CV) adverse factors or causes lasting injury.
  • To analyze the correlation between pre-pregnancy and during-pregnancy CV risk factors.

Main Methods:

  • Utilized data from 296 women in the International Childhood Cardiovascular Cohort (i3C) Consortium.
  • Analyzed pre-pregnancy and during-pregnancy CV risk factors including blood pressure, fasting lipids, and glucose.
  • Calculated correlation coefficients and modeled mean differences, adjusting for confounders.

Main Results:

  • Strong correlations (r=0.30-0.55, p<0.01) were observed between pre- and during-pregnancy CV risk factors.
  • Adjusted mean differences between pre- and during-pregnancy measures were not significant.
  • Correlations were stronger in the first and second trimesters compared to the third.

Conclusions:

  • Pre- and during-pregnancy cardiovascular risk factors are moderately correlated.
  • Findings suggest women susceptible to CV risks enter pregnancy with higher levels rather than pregnancy inducing new effects.
  • This highlights the importance of pre-conception cardiovascular health assessment.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
513
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
69
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
123